Synthesis and Characterization of Anti-HER2 Antibody Conjugated CdSe/CdZnS Quantum Dots for Fluorescence Imaging of Breast Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and Characterization of Anti-HER2 Antibody Conjugated CdSe/CdZnS Quantum Dots for Fluorescence Imaging of Breast Cancer Cells

Published:2009-11-19 Issue:11 Volume:9 Page:9332-9354
ISSN:1424-8220
Container-title:Sensors
language:en
Short-container-title:Sensors

Author:

Tiwari Dhermendra,Tanaka Shin-Ichi,Inouye Yasushi,Yoshizawa Keiko,Watanabe Tomonobu,Jin Takashi

Publisher

MDPI AG

Subject

Electrical and Electronic Engineering,Biochemistry,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry

Link

http://www.mdpi.com/1424-8220/9/11/9332/pdf

Reference55 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease;Cobleigh;J. Clin. Oncol.,1999

4. Trastuzumab-mechanism of action and use in clinical practice;Haudis;N. Engl. J. Med.,2007

5. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor-2 positive breast cancer;Liberato;J. Clin. Oncol.,2007

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells;International Journal of Pharmaceutics: X;2024-06

2. Quantum Dot Research in Breast Cancer: Challenges and Prospects;Materials;2024-05-04

3. Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer;Current Pharmaceutical Biotechnology;2024-04-22

4. Artificial Targets: a versatile cell-free platform to characterize CAR T cell function in vitro;Frontiers in Immunology;2024-02-15

5. Quantum dots as nano drug delivery system;Progress and Prospect of Nanocarriers;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3